$25.88
-0.29 (-1.11%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+52.32%
1Y
+131.28%
YTD
+39.89%
Open$26.51
Previous Close$26.17
Day High$26.77
Day Low$25.58
52W High$26.26
52W Low$9.32
Volume—
Avg Volume3.40M
Market Cap4.70B
P/E Ratio—
EPS$-3.22
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$18.16
Above
SMA 200
$14.91
Above
RSI (14)
28.7
Oversold
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
21 analysts
Price Target
+278.1% upside
Current
$25.88
$25.88
Target
$97.86
$97.86
$76.65
$97.86 avg
$132.93
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 618.44M | 584.19M | 668.57M |
| Net Income | 86.92M | 95.40M | 98.23M |
| Profit Margin | 14.1% | 16.3% | 14.7% |
| EBITDA | 124.54M | 120.89M | 157.55M |
| Free Cash Flow | 66.24M | 92.85M | 89.99M |
| Rev Growth | +16.5% | -3.4% | +9.6% |
| Debt/Equity | 0.27 | 0.23 | 0.33 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $244.33 | -0.76% | 122.9 | 446.67B |
| AMGN | Amgen Inc | $403.48 | -1.07% | 26.5 | 206.48B |
| GILD | Gilead Sciences Inc | $129.97 | -1.36% | 17.6 | 161.72B |
| VRTX | Vertex Pharmaceuticals Inc | $484.53 | -0.06% | 27.8 | 120.52B |
| REGN | Regeneron Pharmaceuticals | $767.54 | -0.14% | 17.5 | 77.36B |
| ALNY | Alnylam Pharmaceuticals Inc | $217.83 | -4.76% | 47.7 | 27.52B |